244. Factor VIII Immunogenicity Is a Barrier to AAV Gene Therapy for Hemophilia A
Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33849-7
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2015
Authors
Publisher
Elsevier BV
Available in full text
May 1, 2015
Elsevier BV